Novel nomograms based on immune and stromal scores for predicting the disease-free and overall survival of patients with hepatocellular carcinoma undergoing radical surgery

摘要

Background Stromal and immune cells play important roles in hepatocellular carcinoma (HCC) development and progression. However, tools for predicting the prognosis of patients with HCC based on stromal and immune scores are not well established. We aimed to develop nomograms that predicted the disease-free survival (DFS) and overall survival (OS) of patients after radical surgery. Methods Basic information of 251 patients were retrieved from The Cancer Genome Atlas. Multivariate Cox analyses identified variables predicting the prognosis of patients. DFS and OS nomograms were constructed based on the stromal and immune scores of the training group and verified in the well-matched test group. Results An intermediate stromal score (hazards ratio [HR] = 3.177;P < .001] was an independent risk factor for DFS. An intermediate immune score independently predicted a longer DFS (HR = 0.323;P = .002) and OS (HR = 0.305;P = .021); a high immune score predicted a longer DFS (HR = 0.289;P = .002). The concordance index (C-index) of nomograms was 0.729 for DFS and 0.696 for OS in the test group. Conclusion Nomograms based on the stromal and immune scores favorably predicted the DFS and OS of patients with HCC after radical surgery.